View
218
Download
1
Category
Preview:
Citation preview
Polycystic Ovarian Syndrome
Amy Mendez, MPH, RD, LD
Registered Dietitian
What is PCOS?
• The most common endocrine disorder affecting women of childbearing age
• 5-20% of reproductive age women
Knochenhauer,et al. J Clin Endocrinol Metab. 1998;83;3078-3082.
Presenting problems
• Oligomenorrhea or Amenorrhea
• Hyperandogenism side effects– Hirsutism– Acne– Male pattern balding
• Infertility
• Obesity/weight gain
PCOS diagnosis
• 2003 PCOS Consensus Workshop new diagnostic criteria (need at least 2 of 3)– Hyperandrogenism (clinical or serum)
• Ex: testosterone
– Chronic Anovulation (avg menses >45 days)– PCOS ovaries on ultrasound
• Exclude other diseases
Long term risks of PCOS
• Type 2 DM- 17-45% incidence
• Dyslipidemia
• Endometrial Cancer
• Hypertension -39% incidence
• MI- risk factors predict 7 fold increase
• Gestational DM- 17-38% incidence
• Pregnancy Induced Hypertension- 14% incidence
• Ovarian Cancer
Hyperandrogenism
Insulin Resistance
Unlikely that the insulin resistance is a result of the hyperandrogenism
• IR remains after BSO
• Pre-pubertal women with acanthosis nigricans are hyperinsulinemic several years before hyperandrogenism occurs
• Some women with point mutations in the insulin receptor have been shown to have PCOS
• Normal men have androgen concentrations 10-30 fold higher than women, yet they do not demonstrate insulin resistance
Elevated Insulin levels
• Studies show that women with PCOS have higher insulin levels than obese controls
• Chang et al, 1983 showed that non-obese PCO pts had higher basal and serum insulin levels than controls
Type 2 Diabetes
Undiagnosed DM IGT
PCOS 7.5% 31.1%
PCOS-non obese 1.5% 10.3%
Age-matched US women 1% 7.8%
Gambineri et al. Diabetes 53(9), 2353-2358.
Metabolic Syndrome:
ATP lll Definition Risk Factor Defining Level• Blood pressure 130 or > 85 mm Hg
• Fasting glucose 100 mg/dL
• TG 150 mg/dL
• HDL-C– Men 40 mg/dL– Women 50 mg/dL
• Waist circumference– Men 102 cm (40 in)– Women 88 cm (35 in)
Ford ES et al. JAMA. 2002;287:356-359.
Therapies for hyperinsulinemia
• Weight loss (obese PCOS)
• Insulin Sensitizers– Troglitozone (Rezulin)– Metformin (Glucophage)– Rosiglitazone (Avandia)– Pioglitazone (Actos)
• Dietary therapies
DPP: Benefit of diet + exercise or metformin on diabetes prevention in at-risk patients
Diabetes Prevention Program (DPP) Research Group. N Engl J Med. 2002;346:393-403.
Years
N = 3234 with IFG and IGT, without diabetes
0
0
10
20
30
40
1.0 2.0 3.0 4.0
Placebo
Metformin
Lifestyle
Cumulative
incidence of diabetes
(%)
31%
58%
P*
<0.001
<0.001
*vs placebo
IFG = impaired fasting glucose
Effect of weight loss
• Diet-induced weight loss of 12.4 kg in 13 obese, insulin-resistant women with PCOS improved: – Fasting insulin – Peak insulin– Insulin AUC– Insulin Sensitivity
Dietary Composition
• 45 women with PCOS
• Randomized to: – high protein (HP; 40% carb, 30% protein;
n=14)– Low protein (LP; 55% carb, 15% protein; n=14
• 12 weeks energy restriction, 4 wk maintenance
High Protein vs Low Protein
• Improvements seen for both groups:– Pregnancies– Menstrual cyclicity– Lipid profile– Insulin resistance– Weight– Abdominal fat
• HP group: HDL remained consistent, LP group: HDL dropped during weight loss
At this time, no clear evidence that diet composition has significant
benefits over the weight loss itself
Reactive Hypoglycemia
• 64 lean women with PCOS
• 50% prevalence of reactive hypoglycemia– Altuntas, et al. Eur J Obstet Gynecol Reprod Biol 2005
• Would a low glycemic load diet pattern be effective to reduce post-prandial hyperinsulinemia?
• Would this dietary pattern reduce “carbohydrate cravings?”
Low Glycemic Load Diet
A.M. Herriot et al. J Human Nutr Dietetics 2008
• 88 patients with PCOS referred for nutrition counseling
• Retrospective audit of records at RD and MD visits
•Subjective reports of hunger and carbohydrate cravings improved
Additional benefits of protective
dietary pattern
Amy Mendez, MPH, RD, LD
Registered Dietitian
843-876-4795
mendeza@musc.edu
Recommended